Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of “mixed” rejection

Marny Fedrigo, Gerald J. Berry, Guillaume Coutance, Elaine F. Reed, Chieh Yu Lin, Alessia Giarraputo, Evan Kransdorf, Olivier Thaunat, Martin Goddard, Annalisa Angelini, Desley A.H. Neil, Patrick Bruneval, Jean Paul Duong Van Huyen, Alexandre Loupy, Dylan V. Miller

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The Banff Heart Concurrent Session, held as part of the 16th Banff Foundation for Allograft Pathology Conference at Banff, Alberta, Canada, on September 21, 2022, focused on 2 major topics: non-human leukocyte antigen (HLA) antibodies and mixed rejection. Each topic was addressed in a multidisciplinary fashion with clinical, immunological, and pathology perspectives and future developments and prospectives.

Original languageEnglish
Pages (from-to)533-541
Number of pages9
JournalAmerican Journal of Transplantation
Volume24
Issue number4
DOIs
StatePublished - Apr 2024

Keywords

  • heart transplantation
  • mixed rejection
  • non-HLA antibodies
  • pathology

Fingerprint

Dive into the research topics of 'Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of “mixed” rejection'. Together they form a unique fingerprint.

Cite this